key: cord-0897618-cd8qfur9 authors: Assar, Shirin; Pournazari, Mehran; Soufivand, Parviz; Mohamadzadeh, Dena; Sanaee, Simindokht title: Microscopic polyangiitis associated with coronavirus disease-2019 (COVID-19) infection in an elderly male date: 2021-03-09 journal: nan DOI: 10.1016/j.ejr.2021.03.001 sha: 8a232f8f91a49a22c3778ff855720e9b86308b90 doc_id: 897618 cord_uid: cd8qfur9 Background Microscopic polyangiitis (MPA) is an antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) that affects predominantly small- sized vessels. A causal relationship between viral infections and vasculitis has been postulated. Aim of the work: To present the concomitant association of coronavirus disease 2019 (COVID-19) infection with MPA in an elderly Iranian male. Case presentation A 67 year old Iranian man with the history of COVID-19 infection and a positive polymerized chain reaction (PCR) test four weeks before admission to the neurology department with acute onset pain, numbness and progressive weakness in both hands grip, sudden left foot drop and paresthesia. Erythrocyte sedimentation rate (ESR) was 95 mm/hr, ferritin 912 ng/ml and C-reactive protein (CRP) positive, proteinuria 1.1 g/24h and markedly elevated perinuclear (P-ANCA): 526 IU/ml. Diagnosis of MPA was held presenting with mononeuritis multiplex, glomerulonephritis followed by diffuse alveolar hemorrhage and infiltration of lymphocytes in muscle fibers and vessels wall in sural nerve biopsy. He was successfully treated by methylprednisolone (1g/day for 3 days) followed by 1 mg/kg with gradual tapering along with cyclophosphamide (CYC) (2 mg/kg). Intravenous immunoglobulin (IVIG, 2 g/kg in four divided doses) started for the management of inflammatory mononeuritis multiplex with gradual improvement. During hospitalization, plasmapheresis was performed due to alveolar hemorrhage for 5 day. The patient returned home on day 32 and followed-up in the rheumatology clinic with improvement of muscle power and handgrip strength. Conclusion Vasculitis is potentially one of COVID-19’s presenting symptoms and prompt diagnosis and treatment is crucial in improving outcome of patients. At the end of 2019 several cases of atypical pneumonia emerged in the Chinese province of Hubei and, in January 2020, severe acute respiratory virus 2 (SARS-CoV-2) was identified as the causative agent of the novel coronavirus disease 2019 (COVID-19) [1] . Signs and symptoms of COVID-19 extending beyond the respiratory tract, The finding can be explained, at least in part, by the ubiquitous expression and tissue distribution of angiotensinconverting enzyme 2 (ACE2), the major SARS-CoV-2 entry receptor [2] . ACE-2 receptor is found also in bowel, endothelium of small vessels, smooth muscle, skeletal muscle and even synovial tissue. [3] It is therefore not unexpected that, some of the symptoms caused by COVID-19 are commonly described in other diseases, for instance, also in patients with rheumatic conditions. Interestingly, the association between viral infections and rheumatic diseases is already well-recognized. In fact during the pandemic, rheumatic disease patients faced remarkable difficulty to obtain their medications with subsequent change in their disease status [4] with a negative impact on their quality of life [5] . There is an agreement to the key emerging frontline role of rheumatologists in treating COVID-19. During the pandemic, RD cases requiring admission are dealt with by modified strategies [6] . Viruses can be direct etiologic agents of acute and chronic arthritis [7] , and of different forms of vasculitis, both in children and adults [8] . Microscopic polyangiitis (MPA) is a member of the family of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV). Its characteristic histology shows a necrotizing small vessel vasculitis with little or absent immune deposits (pauci-immune vasculitis). It affects more men than women and commences at the age of ≥50 years. The two organs most typically involved and often defining prognosis are the kidneys and the lungs. MPA may concomitantly or sequentially involve other organs such as the nervous system, the skin, the musculoskeletal system, but also the heart, the eye and the intestines [9] . Neurologic involvement in MPA is common, and affects between 37-72% of patients [10] . Peripheral neuropathy occurs more frequently than central nervous system involvement, with mononeuritis multiplex and distal symmetrical polyneuropathy as the predominant peripheral nervous system manifestations. Necrotizing vasculitis can be seen on sural nerve biopsy in up to 80% of patients, and nerve conduction studies typically show acute axonopathy [11] . The aim of this case report is to present the concomitant association of COVID-19 infection with MPA in an elderly Iranian male. On November 18 th , 2020, a 67 year old man was admitted to the neurology department at Kermanshah University, Iran. He complained of acute onset pain, numbness and progressive weakness in both hands grip for one week prior to admission and a sudden left foot drop on the day of admission preceded by paresthesia of the left foot. His past medical history included hypothyroidism, on thyroxin supplementation for 3 years and a recent COVID19 infection which was proved by a positive polymerized chain reaction (PCR) test four weeks prior to admission. At that time, his symptoms were fever, malaise and dry cough, and he received naproxen 250 mg twice daily, azithromycin 500 mg daily and diphenhydramine syrup four times a day orally in an outpatient setting. His familial history was unremarkable for autoimmune diseases. The management of the case was approved by the ethical committee of the university and in agreement to the declaration of Helsinki. An informed consent was obtained from the patient for the publication of this case report. On general examination, the vital signs were stable and on admission he was afebrile with pallor. Examination of the respiratory and cardiovascular systems was within normal limits. Neurological examination revealed a conscious and alert patient with normal cranial nerves. On the 17 th day of admission, the patient started to suffer from shortness of breath, cough and hemoptysis. Lung physical examination revealed bilateral basal crepitus. He developed hypoxia needing supplemental oxygen. His hemoglobin decreased gradually despite packed cell infusion. Echocardiography was normal with ejection fraction of 55%. Chest x-ray images revealed diffuse airspace opacities and chest CT scan findings were consistent with diffuse bilateral ground glass alveolar opacity casting the pulmonary lobules together with confluent areas of consolidation opacities and bilateral plural effusion (Figure 1b) . He did not consent to undergo bronchoscopy at this time, but the overall clinical picture was consistent with an alveolar hemorrhage, although COVID-19 pneumonitis was in differential diagnosis. Plasmapheresis was performed for 5 days for suspected alveolar hemorrhage after which he symptomatically improved. The patient returned home on day 32 with slight improvement of peroneal paralysis and handgrip strength. He was followed up in the rheumatology clinic 4 weeks after discharge and his muscle forces and hand grip strength were slightly improved. ESR level and 24 hours urine protein decreased to 22mm/h and 635 mg/24hrs respectively. He was maintained on oral CYC 2 mg/kg daily and oral steroids. The patient's laboratory data on different days is summarized in table 1. Microscopic polyangiitis (MPA) is pathologically characterized by inflammation and fibrinoid necrosis of small vessel walls, leading to multiple organ involvement, including of the kidneys, lung, skin, digestive system, and nervous system. The etiology of ANCAassociated vasculitis (AAV) is considered to involve genetic and environmental factors, such as silica exposure, infections, and drugs [12] . In the current case, vasculitis developed following COVID-19 infection, and this virus may be the etiological factor of the disease. New data suggests that COVID19 infection can present differently and it does not necessarily affect the respiratory system [13] Therefore, SARS2 could be a misnomer for this disease. There are some speculations that the virus could be a direct invader of endothelial cells. [14] In this case vasculitis was probably the consequence of an immuno-inflammatory process, as suggested by the 4-week delay between first symptoms and the development of multiorgan involvement and the positive COVID-19 IgG serological test at the time of admission. Vasculitis can affect a wide variety of organs, including the lungs, kidneys, skin, brain, and peripheral nerve. There is an alteration of the immune system in which it produces autoantibodies; many of them directed against multiple antigens located in the basement membrane of blood vessels. Primary autoantibodies produced are ANCA; their role is essential for the diagnostic orientation of this pathology [15] It could be postulated that the patient's infection with COVID-19 and its subsequent increased inflammatory state led to his developing of MPA with subsequent peripheral nervous system, pulmonary and renal involvement. His clinical and serologic pictures were consistent with a diagnosis of MPA. Biopsy of sural nerve revealed much more lymphocytic infiltration in muscle fibers than vessels wall. MPA diagnosed by muscle specimen has been reported [16] . It is unclear whether the patient had a smoldering vasculitis that was accelerated by the inflammatory state of COVID-19 or whether this virus caused a vasculitis by itself. Although he did not have any respiratory symptoms on admission, lung involvement might have existed, because the ground glass shadows in his lungs gradually progressed over 2 weeks. As far as we know, this case is the first to describe the presence of MPA due to COVID19 infection. Estévez-Rivera and his colleagues, described a 63-year-old woman who developed mononeuritis multiplex, kidney failure and necrotic lesions in the pulp of the knuckles, with positive serum IgG against SARS-CoV-2 but negative serum IgM and oropharyngeal swab PCR and they suggested the possibility of an underlying vasculitis process, but they didn't mention anything about ANCAs or biopsy of affected tissues [17] . This could indicate that In conclusion, although there is no conclusive evidence that COVID-19 can develop vasculitis, this case of MPA was associated with high serum coronavirus IgM and IgG levels and positive PCR test, therefore MPA can potentially be a manifestation of COVID-19 infection, and prompt diagnosis and treatment is very important to improve outcome. The novel coronavirus originating in Wuhan, China: Challenges for global health governance The pivotal link between ACE2 deficiency and SARS-CoV-2 infection Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural-urban gap and north-south gradient Impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection and disease-2019 (COVID-19) on the quality of life of rheumatoid arthritis patients in Benin Rheumatologists' practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt Viral arthritis In: Hospital based dermatopathology: an illustrated diagnostic guide Microscopic polyangiitis: Clinical presentation Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides Mortality and morbidity in peripheral neuropathy associated Churg-Strauss syndrome and microscopic polyangiitis ANCA-associated vasculitides-advances in pathogenesis and treatment Urticaria-like lesions in COVID-19 patients are not really urticaria -a case with clinicopathologic correlation Endothelial cell infection and endotheliitis in COVID-19 Vasculitis and its neurological manifestations Microscopic polyangiitis diagnosed by muscle specimen: a case report and literature review Mononeuritis Multiplex Associated with Sars-Cov2-Covid-19 Infection:Case Report SARS-CoV2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases CT) scan of a 67 year old man (A) on admission day showing patchy ground glass opacities and (B) on the 17 th day diffuse bilateral ground glass alveolar opacity casting the pulmonary lobules together with confluent areas of consolidation opacities and bilateral plural effusion Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.